Overlapping biomarkers, pathways, processes and syndromes in lymphatic development, growth and neoplasia

Marlys H. Witte, Michael T. Dellinger, Cristobal M. Papendieck, Francesco Boccardo

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Recent discoveries in molecular lymphology, developmental biology, and tumor biology in the context of long-standing concepts and observations on development, growth, and neoplasia implicate overlapping pathways, processes, and clinical manifestations in developmental disorders and cancer metastasis. Highlighted in this review are some of what is known (and speculated) about the genes, proteins, and signaling pathways and processes involved in lymphatic/blood vascular development in comparison to those involved in cancer progression and spread. Clues and conundra from clinical disorders that mix these processes and mute them, including embryonic rests, multicentric nests of displaced cells, uncontrolled/invasive "benign" proliferation and lymphogenous/hematogenous "spread", represent a fine line between normal development and growth, dysplasia, benign and malignant neoplasia, and "metastasis". Improved understanding of these normal and pathologic processes and their underlying pathomechanisms, e.g., stem cell origin and bidirectional epithelial-mesenchymal transition, could lead to more successful approaches in classification, treatment, and even prevention of cancer and a whole host of other diseases.

Original languageEnglish (US)
Pages (from-to)707-727
Number of pages21
JournalClinical and Experimental Metastasis
Volume29
Issue number7
DOIs
StatePublished - Oct 2012

Fingerprint

Growth and Development
Biomarkers
Neoplasms
Neoplasm Metastasis
Developmental Biology
Critical Pathways
Epithelial-Mesenchymal Transition
Pathologic Processes
Blood Vessels
Stem Cells
Proteins

Keywords

  • Biomarkers
  • Cancer metastasis
  • EMT-MET
  • Lymphatic development
  • Lymphogenous dissemination
  • Vascular neoplasia

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Overlapping biomarkers, pathways, processes and syndromes in lymphatic development, growth and neoplasia. / Witte, Marlys H.; Dellinger, Michael T.; Papendieck, Cristobal M.; Boccardo, Francesco.

In: Clinical and Experimental Metastasis, Vol. 29, No. 7, 10.2012, p. 707-727.

Research output: Contribution to journalArticle

Witte, Marlys H. ; Dellinger, Michael T. ; Papendieck, Cristobal M. ; Boccardo, Francesco. / Overlapping biomarkers, pathways, processes and syndromes in lymphatic development, growth and neoplasia. In: Clinical and Experimental Metastasis. 2012 ; Vol. 29, No. 7. pp. 707-727.
@article{d4c53eee267d4e49b3503ba5f285cd8c,
title = "Overlapping biomarkers, pathways, processes and syndromes in lymphatic development, growth and neoplasia",
abstract = "Recent discoveries in molecular lymphology, developmental biology, and tumor biology in the context of long-standing concepts and observations on development, growth, and neoplasia implicate overlapping pathways, processes, and clinical manifestations in developmental disorders and cancer metastasis. Highlighted in this review are some of what is known (and speculated) about the genes, proteins, and signaling pathways and processes involved in lymphatic/blood vascular development in comparison to those involved in cancer progression and spread. Clues and conundra from clinical disorders that mix these processes and mute them, including embryonic rests, multicentric nests of displaced cells, uncontrolled/invasive {"}benign{"} proliferation and lymphogenous/hematogenous {"}spread{"}, represent a fine line between normal development and growth, dysplasia, benign and malignant neoplasia, and {"}metastasis{"}. Improved understanding of these normal and pathologic processes and their underlying pathomechanisms, e.g., stem cell origin and bidirectional epithelial-mesenchymal transition, could lead to more successful approaches in classification, treatment, and even prevention of cancer and a whole host of other diseases.",
keywords = "Biomarkers, Cancer metastasis, EMT-MET, Lymphatic development, Lymphogenous dissemination, Vascular neoplasia",
author = "Witte, {Marlys H.} and Dellinger, {Michael T.} and Papendieck, {Cristobal M.} and Francesco Boccardo",
year = "2012",
month = "10",
doi = "10.1007/s10585-012-9493-1",
language = "English (US)",
volume = "29",
pages = "707--727",
journal = "Clinical and Experimental Metastasis",
issn = "0262-0898",
publisher = "Springer Netherlands",
number = "7",

}

TY - JOUR

T1 - Overlapping biomarkers, pathways, processes and syndromes in lymphatic development, growth and neoplasia

AU - Witte, Marlys H.

AU - Dellinger, Michael T.

AU - Papendieck, Cristobal M.

AU - Boccardo, Francesco

PY - 2012/10

Y1 - 2012/10

N2 - Recent discoveries in molecular lymphology, developmental biology, and tumor biology in the context of long-standing concepts and observations on development, growth, and neoplasia implicate overlapping pathways, processes, and clinical manifestations in developmental disorders and cancer metastasis. Highlighted in this review are some of what is known (and speculated) about the genes, proteins, and signaling pathways and processes involved in lymphatic/blood vascular development in comparison to those involved in cancer progression and spread. Clues and conundra from clinical disorders that mix these processes and mute them, including embryonic rests, multicentric nests of displaced cells, uncontrolled/invasive "benign" proliferation and lymphogenous/hematogenous "spread", represent a fine line between normal development and growth, dysplasia, benign and malignant neoplasia, and "metastasis". Improved understanding of these normal and pathologic processes and their underlying pathomechanisms, e.g., stem cell origin and bidirectional epithelial-mesenchymal transition, could lead to more successful approaches in classification, treatment, and even prevention of cancer and a whole host of other diseases.

AB - Recent discoveries in molecular lymphology, developmental biology, and tumor biology in the context of long-standing concepts and observations on development, growth, and neoplasia implicate overlapping pathways, processes, and clinical manifestations in developmental disorders and cancer metastasis. Highlighted in this review are some of what is known (and speculated) about the genes, proteins, and signaling pathways and processes involved in lymphatic/blood vascular development in comparison to those involved in cancer progression and spread. Clues and conundra from clinical disorders that mix these processes and mute them, including embryonic rests, multicentric nests of displaced cells, uncontrolled/invasive "benign" proliferation and lymphogenous/hematogenous "spread", represent a fine line between normal development and growth, dysplasia, benign and malignant neoplasia, and "metastasis". Improved understanding of these normal and pathologic processes and their underlying pathomechanisms, e.g., stem cell origin and bidirectional epithelial-mesenchymal transition, could lead to more successful approaches in classification, treatment, and even prevention of cancer and a whole host of other diseases.

KW - Biomarkers

KW - Cancer metastasis

KW - EMT-MET

KW - Lymphatic development

KW - Lymphogenous dissemination

KW - Vascular neoplasia

UR - http://www.scopus.com/inward/record.url?scp=84868215136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868215136&partnerID=8YFLogxK

U2 - 10.1007/s10585-012-9493-1

DO - 10.1007/s10585-012-9493-1

M3 - Article

C2 - 22798218

AN - SCOPUS:84868215136

VL - 29

SP - 707

EP - 727

JO - Clinical and Experimental Metastasis

JF - Clinical and Experimental Metastasis

SN - 0262-0898

IS - 7

ER -